<DOC>
	<DOCNO>NCT02600585</DOCNO>
	<brief_summary>The primary objective study retrospectively characterize safety Flublok adults 18 year age old , comparison egg-based trivalent quadrivalent inactivate influenza vaccine ( IIVs ) , use methodological approach design query database electronic health record ( EHR ) maintain Kaiser-Permanente , Northern California ( KPNC ) , large medical care organization ( MCO ) .</brief_summary>
	<brief_title>Post-Marketing Observational Study Safety Following Vaccination With FlublokÂ® Compared Licensed IIV Adults</brief_title>
	<detailed_description>The primary analysis nonrandomized , observational retrospective cohort study . Data adult 18 year age old enrol KPNC database risk interval vaccination analyze study vaccinate Flublok IIV ( either IIV3 IIV4 ) identify analysis . The rate occurrence specific MAEs interest pre-specified risk interval follow Flublok IIV compare .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Data EHR adult KPNC member 18 year age old , receive Flublok active immunization influenza part routine medical care within KPNC system . The comparator cohort include data adult age group receive IIV ( trivalent quadrivalent ) period Flublok administration . Healthcare provider expect administer Flublok IIV individual know contraindication either vaccine ( see product package insert ) . However , exclusion age KPNC membership criterion time vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>